Drug Shortage Report for APO-DABIGATRAN

Last updated on 2020-11-20 History
Report ID 122473
Drug Identification Number 02468913
Brand name APO-DABIGATRAN
Common or Proper name DABIGATRAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DABIGATRAN ETEXILATE
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 60 BLS
ATC code B01AE
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-17
Estimated end date 2021-01-22
Actual end date
Shortage status Actual shortage
Updated date 2020-11-20
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-11-20 French Compare
v6 2020-11-20 English Compare
v5 2020-10-01 French Compare
v4 2020-10-01 English Compare
v3 2020-08-19 French Compare
v2 2020-08-19 French Compare
v1 2020-08-19 English Compare